nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilvadipine—CYP2A6—Methoxsalen—psoriasis	0.119	0.131	CbGbCtD
Nilvadipine—CYP2C8—Tazarotene—psoriasis	0.0913	0.101	CbGbCtD
Nilvadipine—CYP1A2—Clobetasol propionate—psoriasis	0.0867	0.0955	CbGbCtD
Nilvadipine—CYP2A6—Prednisolone—psoriasis	0.058	0.0639	CbGbCtD
Nilvadipine—CYP1A2—Methoxsalen—psoriasis	0.0456	0.0502	CbGbCtD
Nilvadipine—CYP2C8—Cholecalciferol—psoriasis	0.039	0.0429	CbGbCtD
Nilvadipine—CACNA1S—pes—psoriasis	0.0355	0.786	CbGeAlD
Nilvadipine—CYP2A6—Dexamethasone—psoriasis	0.0342	0.0377	CbGbCtD
Nilvadipine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0338	0.0372	CbGbCtD
Nilvadipine—CYP2C19—Cholecalciferol—psoriasis	0.0327	0.036	CbGbCtD
Nilvadipine—CYP3A4—Calcitriol—psoriasis	0.0307	0.0338	CbGbCtD
Nilvadipine—CYP2C9—Cholecalciferol—psoriasis	0.0272	0.0299	CbGbCtD
Nilvadipine—CYP2C8—Hydrocortisone—psoriasis	0.0271	0.0299	CbGbCtD
Nilvadipine—CYP2C8—Cyclosporine—psoriasis	0.0256	0.0282	CbGbCtD
Nilvadipine—CYP3A4—Methoxsalen—psoriasis	0.0239	0.0263	CbGbCtD
Nilvadipine—CYP2C19—Prednisone—psoriasis	0.0227	0.025	CbGbCtD
Nilvadipine—CYP2E1—Dexamethasone—psoriasis	0.0226	0.0249	CbGbCtD
Nilvadipine—CYP2C19—Cyclosporine—psoriasis	0.0215	0.0237	CbGbCtD
Nilvadipine—CYP2C9—Cyclosporine—psoriasis	0.0179	0.0197	CbGbCtD
Nilvadipine—CYP2C8—Dexamethasone—psoriasis	0.0169	0.0186	CbGbCtD
Nilvadipine—CYP3A4—Cholecalciferol—psoriasis	0.0158	0.0174	CbGbCtD
Nilvadipine—CYP2C19—Dexamethasone—psoriasis	0.0142	0.0156	CbGbCtD
Nilvadipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0137	0.0151	CbGbCtD
Nilvadipine—CYP3A4—Triamcinolone—psoriasis	0.0137	0.0151	CbGbCtD
Nilvadipine—CYP2C9—Dexamethasone—psoriasis	0.0118	0.013	CbGbCtD
Nilvadipine—CYP3A4—Betamethasone—psoriasis	0.0118	0.0129	CbGbCtD
Nilvadipine—CYP3A4—Prednisolone—psoriasis	0.0116	0.0128	CbGbCtD
Nilvadipine—CYP3A4—Hydrocortisone—psoriasis	0.011	0.0121	CbGbCtD
Nilvadipine—CYP3A4—Prednisone—psoriasis	0.011	0.0121	CbGbCtD
Nilvadipine—CYP3A4—Cyclosporine—psoriasis	0.0104	0.0114	CbGbCtD
Nilvadipine—CYP3A4—Dexamethasone—psoriasis	0.00684	0.00753	CbGbCtD
Nilvadipine—CACNA2D3—tendon—psoriasis	0.00315	0.0699	CbGeAlD
Nilvadipine—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00297	0.0639	CbGpPWpGaD
Nilvadipine—CACNA1S—tendon—psoriasis	0.00272	0.0602	CbGeAlD
Nilvadipine—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00235	0.0505	CbGpPWpGaD
Nilvadipine—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00203	0.0437	CbGpPWpGaD
Nilvadipine—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00184	0.0396	CbGpPWpGaD
Nilvadipine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00181	0.039	CbGpPWpGaD
Nilvadipine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00165	0.0355	CbGpPWpGaD
Nilvadipine—CACNB2—tendon—psoriasis	0.00163	0.0362	CbGeAlD
Nilvadipine—CACNA2D1—tendon—psoriasis	0.00153	0.034	CbGeAlD
Nilvadipine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00146	0.0313	CbGpPWpGaD
Nilvadipine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00126	0.0271	CbGpPWpGaD
Nilvadipine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00112	0.0242	CbGpPWpGaD
Nilvadipine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00102	0.022	CbGpPWpGaD
Nilvadipine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000875	0.0188	CbGpPWpGaD
Nilvadipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000773	0.0166	CbGpPWpGaD
Nilvadipine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000765	0.0165	CbGpPWpGaD
Nilvadipine—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000755	0.0162	CbGpPWpGaD
Nilvadipine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000675	0.0145	CbGpPWpGaD
Nilvadipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000628	0.0135	CbGpPWpGaD
Nilvadipine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00062	0.0133	CbGpPWpGaD
Nilvadipine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000605	0.013	CbGpPWpGaD
Nilvadipine—CYP2E1—tendon—psoriasis	0.000604	0.0134	CbGeAlD
Nilvadipine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000597	0.0128	CbGpPWpGaD
Nilvadipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000552	0.0119	CbGpPWpGaD
Nilvadipine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000523	0.0112	CbGpPWpGaD
Nilvadipine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000516	0.0111	CbGpPWpGaD
Nilvadipine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00049	0.0105	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000479	0.0103	CbGpPWpGaD
Nilvadipine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000466	0.01	CbGpPWpGaD
Nilvadipine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00046	0.0099	CbGpPWpGaD
Nilvadipine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000425	0.00915	CbGpPWpGaD
Nilvadipine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000424	0.00911	CbGpPWpGaD
Nilvadipine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00042	0.00903	CbGpPWpGaD
Nilvadipine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000378	0.00813	CbGpPWpGaD
Nilvadipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000363	0.00782	CbGpPWpGaD
Nilvadipine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000359	0.00771	CbGpPWpGaD
Nilvadipine—CACNA1S—Alzheimers Disease—APOE—psoriasis	0.000358	0.0077	CbGpPWpGaD
Nilvadipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000345	0.00741	CbGpPWpGaD
Nilvadipine—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000329	0.00708	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000318	0.00683	CbGpPWpGaD
Nilvadipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000308	0.00662	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000306	0.00657	CbGpPWpGaD
Nilvadipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000295	0.00634	CbGpPWpGaD
Nilvadipine—CACNA1D—Alzheimers Disease—APOE—psoriasis	0.000291	0.00625	CbGpPWpGaD
Nilvadipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00028	0.00603	CbGpPWpGaD
Nilvadipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000278	0.00597	CbGpPWpGaD
Nilvadipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000277	0.00597	CbGpPWpGaD
Nilvadipine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000277	0.00595	CbGpPWpGaD
Nilvadipine—CACNB2—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000264	0.00568	CbGpPWpGaD
Nilvadipine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.00026	0.0056	CbGpPWpGaD
Nilvadipine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000257	0.00552	CbGpPWpGaD
Nilvadipine—CACNA1C—Alzheimers Disease—APOE—psoriasis	0.000255	0.00549	CbGpPWpGaD
Nilvadipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.00025	0.00538	CbGpPWpGaD
Nilvadipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000227	0.00489	CbGpPWpGaD
Nilvadipine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000225	0.00484	CbGpPWpGaD
Nilvadipine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000225	0.00483	CbGpPWpGaD
Nilvadipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000224	0.00482	CbGpPWpGaD
Nilvadipine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000222	0.00477	CbGpPWpGaD
Nilvadipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.00022	0.00472	CbGpPWpGaD
Nilvadipine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000201	0.00432	CbGpPWpGaD
Nilvadipine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000198	0.00426	CbGpPWpGaD
Nilvadipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000195	0.0042	CbGpPWpGaD
Nilvadipine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000195	0.00419	CbGpPWpGaD
Nilvadipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000194	0.00416	CbGpPWpGaD
Nilvadipine—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000183	0.00394	CbGpPWpGaD
Nilvadipine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000183	0.00394	CbGpPWpGaD
Nilvadipine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000181	0.00388	CbGpPWpGaD
Nilvadipine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000178	0.00383	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000174	0.00375	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—CARM1—psoriasis	0.000173	0.00372	CbGpPWpGaD
Nilvadipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000167	0.00359	CbGpPWpGaD
Nilvadipine—CACNA1S—Alzheimers Disease—TNF—psoriasis	0.000166	0.00356	CbGpPWpGaD
Nilvadipine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000156	0.00337	CbGpPWpGaD
Nilvadipine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000154	0.00332	CbGpPWpGaD
Nilvadipine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000154	0.00331	CbGpPWpGaD
Nilvadipine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000152	0.00326	CbGpPWpGaD
Nilvadipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000151	0.00324	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—CARM1—psoriasis	0.000148	0.00319	CbGpPWpGaD
Nilvadipine—CACNA1S—Alzheimers Disease—TP53—psoriasis	0.000146	0.00314	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—NDUFA5—psoriasis	0.000142	0.00305	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—CARM1—psoriasis	0.00014	0.00302	CbGpPWpGaD
Nilvadipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000136	0.00293	CbGpPWpGaD
Nilvadipine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000135	0.0029	CbGpPWpGaD
Nilvadipine—CACNA1D—Alzheimers Disease—TNF—psoriasis	0.000134	0.00289	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—NDUFA5—psoriasis	0.000134	0.00289	CbGpPWpGaD
Nilvadipine—CACNB2—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000129	0.00278	CbGpPWpGaD
Nilvadipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000129	0.00277	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—CARM1—psoriasis	0.000123	0.00265	CbGpPWpGaD
Nilvadipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000122	0.00263	CbGpPWpGaD
Nilvadipine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000121	0.0026	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—CYP2S1—psoriasis	0.000121	0.00259	CbGpPWpGaD
Nilvadipine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000119	0.00256	CbGpPWpGaD
Nilvadipine—CACNA1D—Alzheimers Disease—TP53—psoriasis	0.000118	0.00255	CbGpPWpGaD
Nilvadipine—CACNA1C—Alzheimers Disease—TNF—psoriasis	0.000118	0.00254	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—NDUFA5—psoriasis	0.000118	0.00254	CbGpPWpGaD
Nilvadipine—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000117	0.00253	CbGpPWpGaD
Nilvadipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000116	0.0025	CbGpPWpGaD
Nilvadipine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000116	0.00249	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—CYP2S1—psoriasis	0.000114	0.00246	CbGpPWpGaD
Nilvadipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000107	0.00231	CbGpPWpGaD
Nilvadipine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000104	0.00224	CbGpPWpGaD
Nilvadipine—CACNA1C—Alzheimers Disease—TP53—psoriasis	0.000104	0.00224	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—CYP2S1—psoriasis	0.0001	0.00216	CbGpPWpGaD
Nilvadipine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	9.02e-05	0.00194	CbGpPWpGaD
Nilvadipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.98e-05	0.00193	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—TYK2—psoriasis	8.83e-05	0.0019	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—LEP—psoriasis	8.26e-05	0.00178	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—TYK2—psoriasis	7.57e-05	0.00163	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.5e-05	0.00161	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—PPARG—psoriasis	7.19e-05	0.00155	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—TYK2—psoriasis	7.17e-05	0.00154	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—LEP—psoriasis	7.08e-05	0.00152	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—LEP—psoriasis	6.7e-05	0.00144	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—NDUFA5—psoriasis	6.63e-05	0.00142	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.48e-05	0.00139	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—TYK2—psoriasis	6.3e-05	0.00136	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—TYK2—psoriasis	6.3e-05	0.00135	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—VEGFA—psoriasis	6.24e-05	0.00134	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.24e-05	0.00134	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—PPARG—psoriasis	6.17e-05	0.00133	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—CARM1—psoriasis	5.89e-05	0.00127	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—LEP—psoriasis	5.89e-05	0.00127	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—PPARG—psoriasis	5.84e-05	0.00126	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.66e-05	0.00122	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—CYP2S1—psoriasis	5.63e-05	0.00121	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—CARM1—psoriasis	5.58e-05	0.0012	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—TYK2—psoriasis	5.4e-05	0.00116	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—VEGFA—psoriasis	5.35e-05	0.00115	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—NDUFA5—psoriasis	5.24e-05	0.00113	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—PPARG—psoriasis	5.13e-05	0.0011	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—TYK2—psoriasis	5.12e-05	0.0011	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—VEGFA—psoriasis	5.07e-05	0.00109	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—NFKB1—psoriasis	4.91e-05	0.00106	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—CARM1—psoriasis	4.9e-05	0.00105	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.85e-05	0.00104	CbGpPWpGaD
Nilvadipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.85e-05	0.00104	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—NDUFA5—psoriasis	4.53e-05	0.000973	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—TYK2—psoriasis	4.5e-05	0.000967	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—VEGFA—psoriasis	4.46e-05	0.000958	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—VEGFA—psoriasis	4.45e-05	0.000958	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—CYP2S1—psoriasis	4.45e-05	0.000957	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—STAT3—psoriasis	4.41e-05	0.000949	CbGpPWpGaD
Nilvadipine—CACNA1S—Axon guidance—IL6—psoriasis	4.32e-05	0.000929	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.22e-05	0.000908	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—NFKB1—psoriasis	4.21e-05	0.000905	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—NDUFA5—psoriasis	4.04e-05	0.000869	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—NFKB1—psoriasis	3.99e-05	0.000857	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—CYP2S1—psoriasis	3.85e-05	0.000828	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—VEGFA—psoriasis	3.82e-05	0.000822	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—TNF—psoriasis	3.82e-05	0.000821	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—STAT3—psoriasis	3.78e-05	0.000814	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.77e-05	0.00081	CbGpPWpGaD
Nilvadipine—CACNB2—Axon guidance—IL6—psoriasis	3.7e-05	0.000796	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—NDUFA5—psoriasis	3.68e-05	0.000792	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—CAT—psoriasis	3.62e-05	0.000779	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—VEGFA—psoriasis	3.62e-05	0.000778	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—STAT3—psoriasis	3.58e-05	0.00077	CbGpPWpGaD
Nilvadipine—CACNA1D—Axon guidance—IL6—psoriasis	3.51e-05	0.000754	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—NFKB1—psoriasis	3.5e-05	0.000753	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—CYP2S1—psoriasis	3.43e-05	0.000739	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.43e-05	0.000739	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—CAT—psoriasis	3.43e-05	0.000738	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—TNF—psoriasis	3.27e-05	0.000704	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—VEGFA—psoriasis	3.18e-05	0.000684	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—STAT3—psoriasis	3.15e-05	0.000677	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—NDUFA5—psoriasis	3.15e-05	0.000677	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—CYP2S1—psoriasis	3.13e-05	0.000674	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—TNF—psoriasis	3.1e-05	0.000667	CbGpPWpGaD
Nilvadipine—CACNA1S—Developmental Biology—IL6—psoriasis	3.08e-05	0.000663	CbGpPWpGaD
Nilvadipine—CACNA1C—Axon guidance—IL6—psoriasis	3.08e-05	0.000663	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—CAT—psoriasis	3.01e-05	0.000648	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.93e-05	0.000631	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—APOE—psoriasis	2.82e-05	0.000605	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—CARM1—psoriasis	2.75e-05	0.000592	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—TNF—psoriasis	2.72e-05	0.000586	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—CYP2S1—psoriasis	2.68e-05	0.000576	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—APOE—psoriasis	2.67e-05	0.000573	CbGpPWpGaD
Nilvadipine—CACNB2—Developmental Biology—IL6—psoriasis	2.64e-05	0.000568	CbGpPWpGaD
Nilvadipine—CACNA1D—Developmental Biology—IL6—psoriasis	2.5e-05	0.000538	CbGpPWpGaD
Nilvadipine—CACNB2—Metabolism—PPARG—psoriasis	2.45e-05	0.000527	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.43e-05	0.000522	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—APOE—psoriasis	2.34e-05	0.000504	CbGpPWpGaD
Nilvadipine—CACNA1D—Metabolism—PPARG—psoriasis	2.32e-05	0.000499	CbGpPWpGaD
Nilvadipine—CACNA1C—Developmental Biology—IL6—psoriasis	2.2e-05	0.000473	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—CARM1—psoriasis	2.17e-05	0.000468	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—CYP2S1—psoriasis	2.07e-05	0.000444	CbGpPWpGaD
Nilvadipine—CACNA1C—Metabolism—PPARG—psoriasis	2.04e-05	0.000439	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.02e-05	0.000434	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—CARM1—psoriasis	1.88e-05	0.000404	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.8e-05	0.000387	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.76e-05	0.000378	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—CAT—psoriasis	1.69e-05	0.000364	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—CARM1—psoriasis	1.68e-05	0.000361	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.64e-05	0.000353	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.57e-05	0.000337	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—CARM1—psoriasis	1.53e-05	0.000329	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.43e-05	0.000307	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.4e-05	0.000302	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—CAT—psoriasis	1.34e-05	0.000288	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—APOE—psoriasis	1.31e-05	0.000283	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—CARM1—psoriasis	1.31e-05	0.000281	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.22e-05	0.000263	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—CAT—psoriasis	1.16e-05	0.000249	CbGpPWpGaD
Nilvadipine—CYP2A6—Metabolism—PPARG—psoriasis	1.15e-05	0.000246	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—APOE—psoriasis	1.04e-05	0.000223	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—CAT—psoriasis	1.03e-05	0.000222	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—CARM1—psoriasis	1.01e-05	0.000217	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—CAT—psoriasis	9.41e-06	0.000202	CbGpPWpGaD
Nilvadipine—CYP2E1—Metabolism—PPARG—psoriasis	9.05e-06	0.000195	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—APOE—psoriasis	8.98e-06	0.000193	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—CAT—psoriasis	8.04e-06	0.000173	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—APOE—psoriasis	8.02e-06	0.000172	CbGpPWpGaD
Nilvadipine—CYP2C8—Metabolism—PPARG—psoriasis	7.82e-06	0.000168	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—APOE—psoriasis	7.31e-06	0.000157	CbGpPWpGaD
Nilvadipine—CYP2C19—Metabolism—PPARG—psoriasis	6.98e-06	0.00015	CbGpPWpGaD
Nilvadipine—CYP2C9—Metabolism—PPARG—psoriasis	6.37e-06	0.000137	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—APOE—psoriasis	6.25e-06	0.000134	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—CAT—psoriasis	6.2e-06	0.000133	CbGpPWpGaD
Nilvadipine—CYP1A2—Metabolism—PPARG—psoriasis	5.44e-06	0.000117	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—APOE—psoriasis	4.82e-06	0.000104	CbGpPWpGaD
Nilvadipine—CYP3A4—Metabolism—PPARG—psoriasis	4.2e-06	9.03e-05	CbGpPWpGaD
